BIOLASE to Reduce Total Offering on Form S-3 From $30 Million to $5 Million
August 14, 2013 at 15:29 PM EDT
BIOLASE, Inc. (NASDAQ: BIOL ), the world's leading manufacturer and distributor of dental lasers, and a pioneer in laser surgery in other medical specialties, today announced that due to the unwarranted amount of confusion in the marketplace that has ensued since the filing of the registration statement on Form